The current study focused on testosterone kinetics after external beam radiation therapy (EBRT) in contemporary patients with localized prostate cancer. The authors hypothesized that these patients would have less significant decreases in serum testosterone and duration when compared to men in the previous studies.
This study aimed to generate consensus reference ranges for total testosterone using data from four epidemiologic studies of men in the United States and Europe.
Testosterone solution 2% is often prescribed to treat testosterone deficiency. This study aimed to determine whether testosterone replacement therapy could improve ejaculatory function in men with hypogonadism.
For some time, there has been concern among physicians that testosterone therapy either leads to prostate cancer or causes undiagnosed prostate cancer to progress. These beliefs have been shown to be a myth; however, many physicians still cite this concern as the main reason for not prescribing testosterone therapy. The current study aimed to address these concerns and describe the long-term outcomes for 1,365 men who tried different forms of testosterone therapy as part of the UK Androgen Study (UKAS).